didanosine

Objective To find out the alterations of the immunological and virological indexes and the emergence of resistant strains in the patients undergoing anti-HIV therapy ( receiving Zidovudine, Didanosine and Nevirapine).

目的了解确山县抗艾滋病病毒（HIV）治疗过程中，接受治疗（治疗方案为齐多夫定胶囊、去羟基甘散和奈韦拉平片）的患者的免疫学和病毒学指标的变化和耐药毒株的出现情况。

Of patients receiving two-year antiretroviral treatment, 48.2 per cent showed signs of drug resistance against a common combination of drugs Zidovudine, Didanosine and Nevirapine.

这些接受了两年抗转录病毒治疗的患者中，有48.2%的患者对常见的鸡尾酒疗法组合齐多夫定（AZT）、去羟基昔（DDI）和奈韦拉平（NVP）的组方治疗显示出了耐药性。

The first 6-months evaluation on the efficacy of combined therapy with didanosine, stavudine and nevirapine in AIDS patients

去羟肌苷散、司他夫定和奈韦拉平联合治疗艾滋病患者6个月疗效观察